Literature DB >> 21802712

Factor IX-R338L (Factor IX Padua) screening in a Dutch population of sibpairs with early onset venous thromboembolism.

Jorine S Koenderman, Rogier M Bertina, Pieter H Reitsma, Marieke C H de Visser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21802712     DOI： 10.1016/j.thromres.2011.07.009

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

Review 1.  Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders.

Authors:  Antonio Girolami; Elisabetta Cosi; Silvia Ferrari; Annamaria Lombardi; Fabrizio Fabris
Journal:  Clin Appl Thromb Hemost       Date:  2017-08-04       Impact factor: 2.389

Review 2.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 3.  New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice.

Authors:  A Girolami; E Cosi; S Ferrari; A M Lombardi; B Girolami
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

4.  Evolutionary insights into coagulation factor IX Padua and other high-specific-activity variants.

Authors:  Benjamin J Samelson-Jones; Jonathan D Finn; Leslie J Raffini; Elizabeth P Merricks; Rodney M Camire; Timothy C Nichols; Valder R Arruda
Journal:  Blood Adv       Date:  2021-03-09

Review 5.  Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX).

Authors:  Antonio Girolami; Silvia Ferrari; Elisabetta Cosi; Claudia Santarossa; Maria Luigia Randi
Journal:  Clin Appl Thromb Hemost       Date:  2018-11-14       Impact factor: 2.389
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.